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SUMMARY
Background—The peptide mastoparan 7 (MST7) stimulated ATP release in human
erythrocytes. We explored intra- and extracellular processes governing the time-dependent
accumulation of extracellular ATP (i.e., ATPe kinetics).
Methods—Human erythrocytes were treated with MST7 in the presence or absence of two
blockers of pannexin 1. ATPe concentration was monitored by luciferin-luciferase based real-time
luminometry.
Results—Exposure of human erythrocytes to MST7 led to an acute increase in [ATPe], followed
by a slower increase phase. ATPe kinetics reflected a strong activation of ATP efflux and a low
rate of ATPe hydrolysis by ectoATPase activity. Enhancement of [ATPe] by MST7 required
adhesion of erythrocytes to poly-D-lysin-coated coverslips, and correlated with a 31% increase of
cAMP and 10% cell swelling. However, when MST7 was dissolved in a hyperosmotic medium to
block cell swelling, ATPe accumulation was inhibited by 49%. Erythrocytes pre-exposure to 10
μM of either carbenoxolone or probenecid, two blockers of pannexin 1, exhibited a partial
reduction of ATP efflux. Erythrocytes from pannexin 1 knockout mice exhibited similar ATPe
kinetics as those of wild type mice erythrocytes exposed to pannexin 1 blockers.
Conclusions—MST7 induced release of ATP required either cell adhesion or strong activation
of cAMP synthesis. Part of this release required cell swelling. Kinetic analysis and a data driven
model suggested that ATP efflux is mediated by two ATP conduits displaying different kinetics,
with one conduit being fully blocked by pannexin 1 blockers.
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General Significance—Kinetic analysis of extracellular ATP accumulation from human
erythrocytes and potential effects on microcirculation.
Keywords
Extracellular ATP; ATPases; Erythrocyte; Pannexin 1
1. INTRODUCTION
In healthy humans, about 40% of the blood volume is occupied by rbcs containing a 1,000-
fold higher ATP concentration than plasma (mM vs μM; (1)). Thus even a limited release of
ATP from the large rbc intracellular pool can result in nano to micromolar concentrations of
ATP (ATPe) in the vascular lumen [1, 2, 3].
Human erythrocytes release ATP upon their exposure to β-adrenergic agonists, mechanical
deformation, reduced oxygen tension, or acidosis [4]. All of these conditions represent
physiological stimuli to which rbcs are exposed in the vasculature, e.g. when passing
through the small branches of the microcirculation [5, 6, 7, 8].
A signaling route leading to ATP release from human rbcs involves the heterotrimeric G
protein Gs, adenylyl cyclases and PKA [3, 9]. In addition to Gs, Gi proteins of these cells
have been proposed to transduce mechanical stress and hypoxia into ATP release [10, 11].
Similarly, the tetradecapeptide MST extracted from wasp venom [12] binds to the plasma
membrane and forms an amphiphilic helix that activates Gi without requiring the activation
of a receptor [13]. MST7, synthesized by substituting alanine for the positively charged
lysine in position 12, acts as a potent analog of MST in human rbcs and other cell systems
[14,15]. Both MST and MST7 are known to activate ATP efflux of human rbcs [15].
The current postulated chain of events linking Gi activation to ATP efflux involves the
dissociation of heterotrimeric Gi, allowing βγ dimers to stimulate specific isoforms of
adenylyl cyclases, and the subsequent increase in cAMP formation. These events are
followed by a series of not-well defined intracellular signaling events upstream of ATP
release [10, 11, 16]. Besides the adenylyl cyclases, βγ subunits interact with various effector
proteins such as ionic channels, phosphatidylinositol-3 kinase isoforms, proteins containing
PDZ domains, and GEFs for small G proteins [17].
The released ATP can primarily act on specific P2X and P2Y purinergic receptors (receptors
for di- and trinucleotides, [2]) on adjacent endothelial cells, or be hydrolyzed by
ectonucleotidases present on the plasma membrane of rbcs and other blood and vascular
cells. Thus ATPe also serves as a reservoir to generate ADP and adenosine, which in turn
activate P2Y and adenosine receptors functionally expressed in rbcs [18, 19] and endothelial
cells [20, 21, 22]. The physiological effects of such ligand-receptor interactions can be
manifold, including the alteration of the vascular tone in the brain, coronary arteries and
skeletal muscle [23, 24].
Despite the accumulated knowledge on the mechanisms mediating ATP release, purinergic
receptor signaling, and the cellular role of various ectonucleotidases [25], little is known
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regarding how the dynamic interaction of these processes controls the kinetics of ATPe
accumulation in the immediate environment of rbcs. This is particularly important in the
microvasculature, where rbcs and other blood cells interact over short distances (within the
micrometer range), and local signals of high energy demand and/or stress can induce ATP
release from erythrocytes. The subsequent extracellular diffusion would permit ATPe to
trigger paracrine responses to these signals. Based on this, the following questions arise: (i)
will ATP release, under a given metabolic condition, be counteracted by ATPe hydrolysis at
the cell surface? This is not unexpected since in most cell types ectoATPase activity follows
a function with [ATPe] [26], (ii) can the released ATP, as part of a postulated negative
feedback system [27, 28], inhibit one or more components that participate in ATP release?
and (iii) what ATP transport mechanisms operate in rbcs?
The non-nucleated human rbcs offer a simple metabolic model to approach these questions,
because they possess glycolysis as the sole pathway for ATP generation and lack
intracellular compartments, so that no exocytotic ATP release can occur in these cells.
Moreover, these cells lack direct cell-cell communication that might increase the available
signaling mechanisms inducing ATP release, which may complicate the analysis of ATPe
regulation. Still, the kinetics of [ATPe] in the rbc model, as in any other cell, is complex
enough due to the non-linear relationships among the different processes that alter ATPe
concentration. For instance, various channels and transporters have been postulated in
human rbcs as candidates for ATP release, although many of them have been rejected
afterwards as main conduits [29].
In mammals, the prime candidate protein mediating conductive ATP release is the
pannexon, a homohexamer of pannexin 1, which is expressed in rbcs [27]. The pannexon
constitutes a large pore by itself or it can be part of a multiprotein complex capable of
carrying anions and signaling molecules from the cytoplasm to the extracellular space [30].
Since MST7 is a robust activator of rbcs ATP release [31, 32, 33], in this study we intended
to understand the kinetics of ATPe by exposing human erythrocytes to this peptide.
We present experimental evidence showing that several potential factors altering the kinetics
of [ATPe] can be experimentally controlled in a way that allows a quantitative description of
ATP transmembrane fluxes, and provides useful information on the underlying mechanisms
enabling such transport.
By fitting a simple mathematical model to the experimental ATPe kinetics of erythrocytes,
and from the analysis of ATP release of rbcs from human, canine and mice (pnx+/+ and
pnx−/−) we demonstrate the existence of two kinetically different ATP pathways mediating
ATP release.
2. MATERIALS AND METHODS
2.1. Chemicals
All reagents in this study were of analytical grade. Mastoparan 7, mastoparan 17,
carbenoxolone, probenecid, firefly luciferase (EC 1.13.12.7), forskolin, isoproterenol,
papaverine, H-89, laminin and collagen were purchased from Sigma-Aldrich (St. Louis,
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MO, USA). BCECF-AM, Fluo 4-AM and D-luciferin were obtained from Invitrogen/
Molecular Probes Inc. (Eugene, OR, USA). [γ-32P]ATP (10 Ci/mmol) was purchased from
Perkin Elmer Life Sciences (Santa Clara, California, USA).
2.2. Isolation of erythrocytes
Human rbcs were isolated as described before [3]. Before the experiments, rbcs were
resuspended in RBC medium containing (in mM) 137 NaCl, 2.7 KCl, 4.72 Na2HPO4, 1.50
KH2PO4, 1.32 CaCl2, 1.91 MgSO4, 5 glucose, 0.5% bovine serum albumin, pH 7.4 at 25ºC,
and 300 mOsm. All procedures conformed to the Declaration of Helsinki and written
informed consent was given by the donors. Erythrocytes from dogs and mice were isolated
similarly to human rbcs.
2.3. Pannexin 1 knockout mice
The pannexin 1 knockout mouse was generated and characterized, as previously described
[34]. Heterozygous mice were bred to produce homozygous pannexin 1 deficient animals.
All animal studies were approved by the Institutional Animal Care and Use Committee and
were performed according to principles outlined by the Animal Welfare and the NIH
guidelines for the care and use of animals in biomedical research. No morphological
differences or cell volume variation were observed between wild type and pannexin 1
knockout mice rbcs through microscopy, hematocrit and cell counting techniques.
2.4. Treatments
ATP release was induced with 10 μM MST7 or a mixture called 3V, which contained 10 μM
isoproterenol, 30 μM forskolin and 100 μM papaverin [3]. Carbenoxolone 10 M or 100 μM
and probenecid 10 μM were used as blockers of ATP release. H-89 10 μM was used as a
PKA inhibitor.
2.5. Extracellular and intracellular ATP measurements
ATPe was measured using firefly luciferase, which catalyzes the oxidation of luciferin in the
presence of ATP to produce light [35; 36]. Two different types of luminometry
determinations were performed, real-time and off-line.
Real-time luminometry measurements were carried out with cells laid on coverslips that
were mounted in the assay chamber of a custom-built luminometer, as previously described
[37]. Because luciferase activity at 37 ºC is only 10% of that observed at 20 ºC [38], to
maintain full luciferase activity, ATP measurements were performed in a cool chamber
acclimated at 20 ºC. Under the experimental conditions, assay volume did not change during
the course of the experiment. Most measurements were performed with 3x106 cells
incubated in 40 μl of RBC medium. Under these conditions the medium has a height of
about 104 μm (height at the coverslip bottom of the chamber equals 0). The time course of
light emission was transformed into ATPe concentration versus time by means of a
calibration curve. Increasing concentrations of ATP from 9 to 3,900 nM were sequentially
added to the assay medium from a stock solution of pure ATP dissolved in RBC medium.
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In the real-time technique ATPe was measured using cells attached to coated coverslips
(denoted as adhered cells), or cells loaded on the coverslip surface in the absence of any
adherent substrate (non-adhered cells). For adhered cells, rbcs were attached on coverslips
coated with 0.001% poly-D-lysine, except in experiments of Suppl. Fig. 3, where coverslips
were coated with 5 μg laminin or with 0.5–5–50 μg collagen.
Results were expressed as [ATPe] at every time point of a kinetic curve (i.e., ATPe
kinetics), with [ATPe] expressed as pmol/106 cells or nM/40 μl. Alternatively, increases in
[ATPe] were evaluated as the difference between [ATPe] at a fixed time point post stimulus
and the basal [ATPe], and are indicated as ΔATP20 (20 min post stimulus, for human rbcs)
or ΔATP5 (5 min post stimulus, for mice rbcs).
For off-line luminometry determinations, suspensions of human rbcs were incubated in the
presence of MST7. Afterwards the rbcs suspension was centrifuged 2 min at 1,000 x g.
ATPe levels were determined in 45 μl of the resulting supernatant. A standard ATP curve
was obtained for each experiment. Results are indicated as ΔATP10 which results from
subtracting [ATPe] basal values to [ATPe] at 10 min post stimulus.
The intracellular content of ATP was estimated in real-time measurements, using adhered
erythrocytes (3x106 cells). Following rbcs permeabilization with digitonin (50 μg/mL), the
released cytosolic ATP was measured by luminometry as described for ATPe. After
considering the total volume occupied by all rbcs present in the chamber, and the relative
solvent cell volume [39], ATP values were expressed as the intracellular ATP concentration
of rbcs. Changes in cell volume induced by MST7 were taken into account.
2.6. Kinetics of cytosolic free calcium (Ca2+i)
Human rbcs (3x106 cells) were attached to 0.001% poly-D-lysine-coated coverslips. Rbcs
were incubated in RBC medium containing 5 μM Fluo-4 AM for 1 hour at 37 °C.
Subsequently, the solution was washed three times with RBC medium at room temperature
to eliminate extracellular Fluo-4, and coverslips were mounted on a measuring chamber of
an inverted Nikon TE-200 epifluorescence microscope. Fluorescence intensity was
determined at 0.5 min intervals (λexcitation 495 nm, λemission: 510 nm). Images were
acquired with a charge-coupled device camera (Hamamatsu C4742-95) and the Metafluor
acquisition program (Universal Imaging).
All measurements were made at 20°C. Cells were incubated in the absence and presence of
MST7. After each experiment, minimal fluorescence intensity (Fmin) was obtained by
addition of 0.5 mM EGTA in a Ca2+ free medium. Maximal fluorescence intensity (Fmax)
was obtained after addition of 2 mM CaCl2. Both measurements were performed in the
presence of 10 μM of the calcium ionophore ionomycin and used to calibrate the acquired
data. Results were transformed into Ca2+i concentrations by using the following equation
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with a dissociation constant (Kd) of 345 nM [40]. F represents the intensity of fluorescence
at each time. Results were corrected considering the observed changes in cell volume
induced by MST7 (see “Cell volume” below).
2.7. Hydrolysis of ATPe
The rate of ATPe hydrolysis was determined by following the accumulation of [32P]Pi
release from exogenous [γ-32P]ATP added to a rbcs suspension of known hematocrit, as
described before [41; 3] and by real-time luminometry. Briefly, in the first technique the
reaction was started by adding [γ-32P]ATP (0.27Ci/mmol; from 150 to 900 nM) to cell
suspensions at room temperature. At different times, a 200 μL aliquot of the suspension was
withdrawn and centrifuged at 900xg during 30 s, and 100 μL of the supernatant were poured
into 750 μL of a stop solution containing 4.05 mM (NH4)6Mo7O24 and 0.83 mM HClO4.
The ammonium molybdate solution formed a complex with the released phosphate, which
was then extracted with 0.6 mL of isobutyl alcohol. Phases were separated by centrifugation
at 1,000xg for 5 min, aliquots of 200 μL of the organic phase containing [32P]Pi were
transferred to vials with 2 mL of 0.5 M NaOH and radioactivity was measured by the
Cerenkov effect. Initial [32P]Pi concentrations were measured in assay medium lacking
cells. Because the uptake of ATP by rbcs is extremely low, any hydrolysis of [γ-32P]ATP
into ADP + [32P]Pi in a cell suspension can be defined as ecto-ATPase activity, the time
course of which yields a measure of the rate at which one or more ectonucleotidases
hydrolyse ATPe. To calculate ectoATPase activity, time dependent levels of Pi were fitted to
where Y and Y0 are the values of [32Pi] at each time (t) and at t=0, respectively; A
represents the maximal value for the increase in Y with time and k is a rate coefficient. The
parameters of best fit resulting from the regression were used to calculate the initial rate of
ectoATPase activity (vi) as k x A (i.e. the first derivative of Equation 1 evaluated at t = 0).
The [32Pi] mass produced from [γ-32P]ATP was calculated using the ATP specific activity.
To determine ectoATPase activity by real-time luminometry, coverslips with cells
suspension (3 x 106 cells or 30 x 106 cells) were mounted in the measuring chamber of the
luminometer and exposed to luciferase reaction mix. Light emission was measured for 20
min, and then ATP was added to the chamber at final concentrations of 103, 206 and 326
and 863 nM (in separate experiments), and light emission was recorded for another 20 min.
Recorded light output was transformed into ATPe concentration vs. time by means of a
calibration curve and the initial rate of disappearance of ATPe (vi) was estimated from
ATPe kinetics.
For both the radioactive and the luminiscence method, ectoATPase activity was expressed as
fmol Pi/106 cells/min.
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2.8. Hemolysis measurements
An enzymatic method was used to detect microquantities of free hemoglobin [42]. Under the
experimental conditions, as little as 0.006% hemolysis can be detected. Experiments with
detectable free hemoglobin were discarded to avoid the contribution of ATPe content by
hemolysis.
The methods used to measure cyclic AMP and the kinetics of cell volume from human
erythrocytes have been described before [19, 3].
2.9. Data analysis
Statistical significance was determined using one-way analysis of variance followed by a
Turkey-Kramer test of multiple comparisons. A p value ‹ 0.05 was considered significant.
Numbers of determinations (n) from independent preparations (N) are indicated. For
experiments on the time course of both, Vr and Ca2+i, 20–30 cells from 4 or 5 independent
preparations were used.
3. RESULTS
3.1. Effect of hematocrit on [ATPe] of MST7-exposed human rbcs
Determinations of [ATPe] were performed by off-line luminometry at a fixed time point
(Suppl. Fig. 1). The response of human rbcs suspensions to a 10 min MST7 exposure
(ΔATP10) was examined at different hematocrit values ranging from 0.075 to 20%. Results
showed an increase of ΔATP10 with hematocrits in the higher range, since e.g. at
hematocrits 5% and 20% the [ATPe] increased 4- and 17-folds the basal values,
respectively. In the 0.75% and 0.075% range of hematocrit no significant changes in Δ
ATP10 were observed.
Subsequent experiments were performed using the real-time luminometry protocol for
[ATPe] determination.
3.2. ATPe kinetics of MST7 exposed human rbcs
In Fig. 1 a quantification of the time dependent accumulation of ATPe is shown, and
denoted as ATPe kinetics, which depends on the rates of ATP release (increasing [ATPe])
and extracellular ATP hydrolysis (decreasing [ATPe]).
In unstimulated human rbcs, both in the absence or presence of cell adhesion to poly-D-
lysine coated coverslips, [ATPe] remained steady at 0.50 ± 0.11 pmoles/106 cells. In non-
adhered human rbcs MST7 did not affect [ATPe] (Fig. 1A). Lack of response to MST7 was
also evident when non-adhered cells where co-incubated in the presence of soluble lysine
(67 mg/mL) or soluble poly-D-lysine (0.01 mg/mL) (Fig. 1B).
However, in cells attached to poly-D-lysine coated coverslips, MST7 promoted an acute, 7-
fold increase in [ATPe] followed by a slower increase phase, with [ATPe] amounting to
3.41 ± 0.25 pmoles·/106 cells at 20 min post-stimulus (Fig. 1A). ATPe kinetics was well
described by the sum of two increasing exponential functions of time: a fast phase spanning
about 70% of total [ATPe] change with t1/2 = 0.146 ± 0.003 min and a slow phase with t1/2
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= 6.1 ± 0.1 min. In similar experiments using more prolonged MST7 exposures, [ATPe]
achieved a steady state value (Suppl. Fig. 2).
Exposure of adhered cells to MST17, an inactive analogue of MST7, was not different from
basal values. Pretreatment of rbcs with PTX, which uncoupled Gi/o from their effectors,
inhibited MST7-induced ATPe accumulation by 89% ([ATPe] = 0.85 ± 0.12 pmoles/106
cells after 20 min) (Fig. 1C).
In separate experiments, release of ATP was also observed when cells were attached to
either laminin- or collagen- coated coverslips (Suppl. Fig. 3).
3.3. Effect of cell volume on ATPe kinetics of MST7 exposed human rbcs
Changes in the volume of rbcs may alter signaling mechanisms leading to ATP efflux, with
concomitant changes in ATPe kinetics. Therefore the possibility that cell volume may be
affected by MST7 exposure was investigated.
When challenged with 10 μM MST7 in RBC isosmotic medium, cells swelled acutely by 10
% (Vr= 1.10 ± 0.01; N=8). The time course of Vr changes was well described by the sum of
two increasing exponential functions of time (Fig. 2A): a fast phase spanning about 50% of
total Vr change with t1/2 value of 0.04 min and a slow phase with t1/2 = 5 ± 2 min.
Since a slight hyposmotic treatment (in the absence of MST7) induced a small swelling and
[ATPe] increase (Suppl. Fig. 4), the relationship between MST7 effect on ATPe kinetics and
on the observed changes in cell volume was evaluated.
To this end, MST7 was prepared in a hyperosmotic medium (345 mosM) to fully block cell
swelling (Fig. 2A). Under this condition ATPe accumulation was partially inhibited (Fig.
2B) with respect to that observed in isosmotic medium.
In hyperosmotic medium ATPe kinetics was well described by the sum of two exponential
functions of time with similar t1/2 values as those observed with MST7 in isosmotic
medium: a fast phase with t1/2 = 0.23 ± 0.01 min and a slow phase with t1/2 = 5.4 ± 0.2 min.
3.4. Intracellular signaling
To investigate second messengers mediating ATP release, the effect of MST7 on the
concentrations of cytosolic cAMP and calcium (Ca2+i) from human rbcs was evaluated. The
concentration of cAMP increased by 31% in the presence of MST7, and by 77% in the
presence of MST7 and CTZ (phosphodiesterase 3 inhibitor), whereas the incubation with
CTZ alone had no effect (Fig. 3A). This means that phosphodiesterase 3 endogenous activity
was able to partially limit MST7 induced increases of [cAMP].
To test the involvement of MST7-dependent increases in cAMP on ATP release, we
examined the effects of the PKA inhibitor H-89 on ATPe kinetics. Cells were pre-incubated
for 5 min with 10 μM H-89 and ATPe kinetics was monitored upon MST7 addition (not
shown). Under the present experimental conditions, H-89 inhibited ΔATP20 by 47 % (Fig.
3B).
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Exposure of rbcs to MST7 did not affect [Ca2+i] (Fig. 3C).
3.5. Cell adhesion and cAMP as potential modulators of ATP release in rbcs from humans
and dogs
We have shown above in Fig. 1 that in human rbcs MST7 promoted release of ATP required
cell adhesion, and that elevated [ATPe] correlated with an increase in [cAMP] (Fig. 4B). To
evaluate the role of cAMP we also performed experiments in dog rbcs, which were reported
not to exhibit cAMP dependent induction of ATP release [9].
Similarly to human rbcs, exposure of dog erythrocytes to MST7 produced no effects on non-
adhered cells, whereas in adhered cells an acute 12-fold increase of [ATPe] was found (Fig.
4A). Dog rbcs treated with MST7 showed a slight [cAMP] increase, but such change was
not significant. A correlation plot depicts the changes in cAMP and ATPe concentrations
from dog and human rbcs in the absence (basal levels) or presence of 10 μM MST7 (Fig.
4B). Compared to dog rbcs, human rbcs showed a higher response to MST7 for both
parameters assessed.
3.6. EctoATPase activity from human rbcs
Using suspensions of intact human rbcs, the rate of ATP hydrolysis was determined by
following the time course of [32P]Pi accumulation released from [γ-32P]ATP (150–900 nM)
(Fig. 5A). The rate of ATPe hydrolysis was not affected by MST7 exposure of cells.
EctoATPase activity was calculated both, as the initial rate of [32P]Pi accumulation
(estimated from Fig. 5A) of cell suspensions, or alternatively as the initial rate of ATPe
extinction monitored by real-time luminometry using non-adhered cells (data not shown).
EctoATPase activity followed a linear function with ATP concentrations over an ample
range (Fig. 5B).
3.7. Conduits of ATP release in human and mice rbcs
We previously reported that pannexin 1 inhibitors reduced ATP release from rbcs exposed to
a cAMP generating cocktail [3]. Therefore, the possibility that pharmacological inhibition of
pnx by CBX and PBC may inhibit MST7 induced ATP release of human rbcs was
investigated.
Cells pre-incubation with 10 μM or 100 μM CBX, 10 μM PBC, or 10 μM of both CBX and
PBC caused a 2–5 fold reduction in the initial rate of [ATPe] increase, and almost complete
inhibition of the slower increase late phase (Fig. 6A).
Consequently, ΔATP20 values were reduced 47–52% with CBX (10 and 100 μM) or PBC
(10 μM), and 68% with 10 μM CBX + 10 μM PBC. No significant differences in ΔATP20
values were found among the different blockers and concentrations (Fig. 6B).
To investigate further the role of pnx on ATP release from human rbcs, key experiments
were repeated using rbcs from pnx+/+ and pnx−/− mice exposed to either MST7 or the
cAMP-activating cocktail 3V (a cAMP activating cocktail containing 10 μM isoproterenol,
30 μM forskolin and 100 μM papaverine).
Denis et al. Page 9
Biochim Biophys Acta. Author manuscript; available in PMC 2014 October 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
We previously reported that in human rbcs the increase of [ATPe] induced by 3V (Fig. 10)
was fully blocked by 10 μM CBX [3]. Similarly, in pnx+/+ mice rbcs exposed to 3V, an
acute induction of ATPe accumulation occurred that was fully blocked by CBX. On the
contrary, in rbcs from pnx−/− mice, 3V was unable to increase [ATPe] from basal values
(Fig. 7A).
MST7 exposure of pnx+/+ mice rbcs caused an acute 5-fold increase of [ATPe] to a constant
value. An activation of ATPe accumulation was also observed in rbcs from pnx−/− mice, but
absolute levels were reduced by 57% when compared with control pnx+/+ values (Fig. 7B).
In pnx+/+ mice rbcs, pre-incubation with either 10 μM CBX, 10 μM PBC or 10 μM CBX +
10μM PBC reduced MST7 dependent [ATPe] levels by 63–75% (Fig 8A). Absolute [ATPe]
values (estimated as ΔATP5) in the presence of these blockers were similar to that obtained
using rbcs from pnx−/− mice (Fig 8B). Blockers had no effect on [ATPe] of MST7 exposed
rbcs from pnx−/− mice (Fig. 8C and D).
Finally, the response to MST7 was analyzed using rbcs from pnx+/+, pnx+/− and pnx−/−
mice. When compared to pnx+/+ rbcs, ΔATP5 was 62% in pnx+/− mice rbcs and 43% in
pnx−/− mice rbcs, though differences between cells from pnx+/− and pnx+/+ mice were not
significant (Fig. 9).
3.8. Effect of 3V on MST7-ATPe release from non-adhered human rbcs
Experiments in Fig. 10 were designed to check if MST7, when used with 3V as a co-
stimulus, would be able to stimulate ATP release in the absence of cell adhesion. The
cocktail 3V was previously optimized to induce an acute cAMP-dependent ATP release in
human rbcs [3]. Unlike in the case of MST7, 3V effect on ATPe kinetics was similar in the
absence or presence of cell adhesion (Fig. 10A and B).
When non-adhered cells were simultaneously stimulated with 3V and MST7, an acute and
strong increase of [ATPe] was obtained to a maximal value at 3.4 ± 0.6 pmol/106 cells,
which remained constant thereafter (Fig. 10A). Similar experiments performed in the
presence of MST7 and either 10 μM isoproterenol or 30 μM forskolin (two components of
3V mixture) produced minor increases in [ATPe] (Fig. 10C).
3.9. Modeling ATPe kinetics of MST7 estimulated rbcs
Results of Figs. 2 and 5 showed that in human rbcs MST7 induced a slight cell swelling and
a non-linear accumulation of ATPe, while at the same time cells displayed ectoATPase
activity over a wide range of nanomolar concentrations. We next built a data-driven
mathematical model to quantify how these processes control ATPe kinetics and to predict
the kinetics of transmembrane ATP transport mediating ATP release.
3.9.1. Fluxes mediating ATP release—Exposure of human rbcs to 10 μM CBX
induced a partial inhibition of ATPe kinetics (Fig. 6). This was interpreted in the model by
assuming that ATP release (JR) required two conduits (mediating subfluxes JR1 and JR2),
with one subflux (JR1) being fully blocked by CBX (Fig. 11A).
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Model fitting to experimental data allow simulating the kinetics of ATPe in the absence or
presence of CBX with reasonable accuracy, and to predict the corresponding subfluxes
mediating ATP transport (Appendix Fig. 1).
Following MST7 stimulation, JR showed a steep, 1.5 x 104-fold increase from 0.044 to 668
nM/min in less than 1 sec, followed by a slow nonlinear decrease to a constant value of 1.3
nM/min. JR1 showed a high initial amplitude followed by a steep decay.
On the other hand JR2, which acted as the only transport conduit in the presence of CBX,
presented a different kinetics. It increased to a maximum only 18 of JR, but since the decay
rate was slow, after 40 sec JR2 was higher than JR1 (see inset to Fig 11B). Thus, JR2 became
the main subflux of ATP release.
During MST7 exposure the rate of ATPe hydrolysis was very low compared to JR. Hence,
the effect of ectoATPase activity on ATPe kinetics was negligible.
3.9.2. EctoATPase activity—During MST7 exposure the rate of ATPe hydrolysis was
very low compared to JR. Thus, the effect of ectoATPase activity on ATPe kinetics is
expected to be minor. Accordingly, when the best fitting curve of ATPe kinetics (which
takes into account the measured ectoATPase activity) was compared to a predicted ATPe
kinetics assuming full blockage of ectoATPase activity, the differences between both curves
were almost negligible (Appendix Fig. 1 C). On the contrary, when a standard ectoATPase
activity (about 43 times that of human rbcs, as observed in most cell types, [43]) is fed into
the model, the predicted ATPe kinetics departed strongly from the best fitting curve,
reflecting the potential importance of ATPe hydrolysis in controlling ATPe kinetics.
3.9.3. Cell volume—Experimental results showed that in a standard isosmotic medium
MST7 induced cell swelling and ATP efflux. The resulting time-dependent ATPe
accumulation was highly reduced when MST7 was used in a hyperosmotic medium where
changes in cell volume were blocked (Fig. 2). Following model-dependent fit to these data
the predicted fluxes under both experimental conditions (i.e., MST7 in isosmotic and
hyperosmotic media) could be deduced. As compared to MST7 in isosmotic medium, in
hyperosmotic medium the initial peak of ATP flux decreased 70% whereas the decay phase
remained almost unaltered (Appendix Fig. 2 A and B).
Volume-dependent changes in ATPe kinetics might be due to a decrease in intracellular
ATP concentration which, according to the model (Appendix, Eq. 3) is one of the main
factors driving ATP efflux. Alternatively, cell volume may affect the permeability
parameters of the conduits mediating ATP transport (see Appendix).
Since MST7 did not affect ATPi content (basal ATPi content was 192.4 ± 15.5 pmol/106
cells, and after 10 min of MST7 exposure it was 178.8 ± 10.8 pmol/106 cells), changes in
[ATPi] should be inversely related to cell volume. However, when [ATPi] was allowed to
decrease in the model as a function of cell volume enhancement, the predicted effects on
ATPe kinetics were minor (Appendix Fig. 2 C). This means that MST7-dependent swelling
affected ATPe kinetics mainly by controlling ATP permeability.
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4. DISCUSSION
The main goal of this study was to identify the key factors controlling ATPe kinetics of
human rbcs exposed to MST7. In addition to a quantitative analysis of the dynamic balance
between ATP efflux and ATPe hydrolysis yielding a particular ATPe kinetics, we looked
into potential modulators of ATPe release such as Ca2+i, cAMP formation, cell adhesion and
cell swelling.
4.1. Stimuli triggering ATP release
4.1.1. Cell adhesion—In standard off-line measurements of ATPe (11), experiments are
usually performed with rbcs in suspensions at relatively high hematocrits to approach the in
vivo condition where these cells occupy about 40% of blood volume. However, under this
condition, to avoid their natural tendency to sediment, rbcs are subjected to mechanical
forces due to medium agitation, stirring and/or collisions among cells. In a previous report
we demonstrated that such forces can by themselves modulate the potency of other ATP
release stimuli [3]. On the other hand, in real-time ATPe measurements used in the present
study, cells remain quiescent on the bottom of the chamber during the experiment, with
reagents added by diffusion and without medium exchange. Therefore, the present protocol
minimized those external forces and allowed us to assess ATP release in a more controlled
environment.
As a first approach we compared the response to MST7 recorded by ATPe off-line
measurements that required holding rbcs in suspension, with data obtained by ATPe real-
time measurements with quiescent rbcs.
Using rbcs suspensions at 20% hematocrit, exposure to MST7 induced a strong increase in
[ATPe], thus corroborating previous reports [10, 16]. However, the magnitude of the
response decreased with the hematocrit, so that MST7 activation was lost below 1%
hematocrit. A tentative explanation would be that as the hematocrit decreases, cells in
suspension are more diluted and therefore less prone to mechanical perturbations that may
be required to trigger ATP release upon MST7 stimulation.
Similarly to the low hematocrit condition, in the online ATPe measurements where cells
were held quiescent at the bottom of the chamber, MST7 did not alter [ATPe]. However,
MST7 activated ATP release when cells were adhered to coverslips pre-coated with 0.001%
poly-D-lysine. At such a very low concentration of poly-D-lysine (about 10 times lower than
that used in most studies; [44]), negatively charged human rbcs adhered firmly to the
positively-charged surface and remained discoidal in shape [45]. Interestingly, MST7-
induced ATP release was also observed when cells were adhered to collagen- or laminin-
coated coverslips, whereas addition of L-lysine or poly-D-lysine to assay medium
containing non-adhered cells did not produce any response per se. Therefore, cell adhesion
itself, but not the electric charge, may act as a pre-stimulus triggering MST7 activation of
ATP efflux.
4.1.2. Cell volume—Another novel aspect of MST7 action on human rbcs is the induction
of isosmotic swelling. Since a slightly hyposmotic medium caused similar increases in cell
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volume as MST7 in isosmotic medium, and triggered the release of ATP (Suppl. Fig. 4), we
hypothesized that swelling might be one of the components contributing to MST7-induced
ATP release. Accordingly, when MST7 was added in a hyperosmotic medium that fully
blocked cell swelling, the accumulation of ATPe was attenuated. Hence, small increases in
cell volume, probably inducing mechanical forces on the cell surface, were able to positively
modulate the effect of MST7 on ATP release from human rbcs.
In line with this idea, [ATPe] is enhanced by mechanical deformations when rabbit rbcs are
forced to cross small filters [10] or when human rbcs transit along microfluidic channels
[46].
Moreover, using off-line measurements at high hematocrits, MST7 activation of ATP
release was blocked by Bordetella pertussis toxin, implying the involvement of a Gi-
dependent mechanism of ATP release [10]. In our online setup system a similar incubation
treatment with pertussis toxin produced 89 % inhibition of ATPe accumulation, suggesting
that a second –though minor– Gi-independent mechanism of MST7 induced ATP release
might be operative as well.
4.1.3. Intracellular signaling—During the past 15 years, experimental evidence
extensively supported the role of cAMP as an important signal that triggers ATP release
from human, rat, mouse and rabbit rbcs [9, 47, 48, 49], whereas potential effects of Ca2+i
have not been described. Dog erythrocytes were sometimes used as negative controls for the
action of cAMP-dependent stimuli, since they appeared not to exhibit a pathway for cAMP-
dependent ATP release [3, 9].
In the present study, exposure of human rbcs to MST7 did not change [Ca2+i], but caused a
small although significant increase in [cAMP]. Supporting the notion that PKA mediates
cAMP-dependent ATP release, we showed that H-89, a potent inhibitor of PKA, attenuated
MST7-induced ATPe accumulation.
On the other hand, in dog rbcs challenged with MST7, a trend towards increased [cAMP]
was observed but such changes were not significant. In spite of this difference, and even
when dog rbcs were reported not to release ATP in response to deformation, hypoxia, or by
treatment with activators of adenylyl cyclases or cAMP analogs [9], these cells responded
similarly to human rbcs in that non-adhered cells did not respond to MST7, whereas poly-D-
lysine-adhered cells did respond with a significant increase in [ATPe].
Results discussed above indicate that, for quiescent rbcs, an increase in [cAMP] does not
trigger ATP release unless cells are pre-activated by adhesion. But, is it possible to prime
non adhered cells to respond to MST7?
In a previous report we demonstrated that a cAMP activating cocktail (so-called “3V”)
containing isoproterenol (a β-adrenergic agonist), forskolin (an activator of adenylyl
cyclases) and papaverine (a phosphosdiesterase inhibitor) strongly increased [cAMP] and
triggered ATP release from human rbcs [3]. Unlike MST7, 3V did not alter cell volume, and
induced the same ATPe kinetics in the absence or presence of cell adhesion. Interestingly,
the simultaneous addition of 3V and MST7 to non-adhered cells produced a strong ATP
Denis et al. Page 13
Biochim Biophys Acta. Author manuscript; available in PMC 2014 October 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
release, yielding a similar ATPe kinetics than that obtained by incubating adhered cells with
MST7.
This cAMP “rescue” of MST7 effect may require a robust and persistent cAMP elevation
since activation of adenylyl cyclase by β-adrenergic stimulation or forskolin, in the absence
of phosphodiesterase inhibition produced only a slight change in [ATPe]. Thus, in quiescent
human rbcs, either cell adhesion or the stimulation of cAMP synthesis by 3V is required for
MST7 to induce ATP release.
4.2. ATP efflux and ATPe regulation
Exposure of human rbcs to MST7 led to a non-linear increase in [ATPe] (Fig. 1) until a
steady level was achieved. EctoATPase activity, a potential consumer of ATPe, behaved
strictly as a linear function of ATPe concentration and cell density (Fig. 5).
The specific ectoATPase activity was very low compared to other cell types, a feature
shared by all non-nucleated mammalian rbcs [3, 43]. However, if assessed in vivo with 40%
hematocrit this ATPe hydrolyzing activity of rbcs would consume ~6% of total plasma ATP
per minute. It means that the contribution of ectoATPase activity from rbcs to total ATPe
hydrolysis in blood is important (a feature neglected in most studies), because the low
specific ectoATPase activity is compensated by the high abundance of rbcs in blood.
However, in our online measurements performed at low cell density, where the volume of 3
x 106 cells occupied less than 1% of total assay volume, the calculated ATPe consumption
by ectoATPase activity was so low that time-dependent ATPe accumulation mainly
reflected the kinetics of ATPe release.
Due to the absence of vesicles, conductive or transport mechanisms are responsible for rbcs
ATP release. Among them, pannexin 1 has been postulated to form hexameric pores that
allow or facilitate passive transport of ATP across the plasma membrane [50]. Pannexin 1-
activity can be blocked by CBX or PBC [29] and channel activity consistent with pannexin 1
was recorded in membrane patches excised from human rbcs [51].
By assuming two conduits mediating ATP transmembrane transport, our mathematical
model predicted the kinetics of the two corresponding partial fluxes.. A CBX-sensitive flux
was rapidly activated and deactivated, whereas a CBX-resistant flux, smaller in magnitude
than the other one, showed a rapid activation phase followed by a slow decay (Appendix
Fig. 1 B). Clearly, during the first 40 sec of MST7 exposure, ATP release was mainly
controlled by the CBX-sensitive flux, whereas the CBX-resistant flux became important
beyond that time point. As shown in Appendix Fig. 1 A, the best fit model was compatible
with a certain degree of interaction between the two conduits. This is because, according to
the model, CBX not only blocked the CBX-sensitive flux, but was also capable of affecting
the kinetic parameters of the CBX-resistant flux.
To better assess the role of pannexin 1 on ATP efflux, several experiments were repeated
using rbcs from pnx+/+ and pnx−/− mice. Two important features of MST7-induced ATPe
kinetics were similar in rbcs from humans and mice: upon rbcs exposure to MST7, there is a
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time-dependent steep increase in [ATPe] that could be partially inhibited by either CBX or
PBC.
Provided CBX specifically inhibited pannexin 1, rbcs from pnx−/− mice should display
similar ATPe kinetics than those of pnx+/+ mice pre-incubated with CBX. This was indeed
what we found (Fig. 8). Also, rbcs from pnx−/− reached MST7-induced ATPe levels similar
to those of rbcs from pnx+/+ mice pre-incubated with CBX, PBC, or CBX plus PBC.
Importantly, none of these blockers altered [ATPe] of rbcs from pnx−/− mice. Similarly, a
probenecid-tolerant release of ATP was also observed in rbcs from pnx−/− mice stimulated
by a hypotonic K+ solution [52].
Although these results do not solve the issue of whether pannexin 1 acts as a single conduit
or as an essential component of a transport protein complex (as postulated by Silverman et
al., [30]), they indicate that pannexin 1 is the major, if not the only CBX-sensitive pathway
for ATP release from rbcs exposed to MST7 and to a cAMP activating cocktail. Moreover,
most of the predicted initial 15,000-fold increase in ATP efflux required for MST7
dependent ATPe kinetics is due to activation of this CBX-sensitive pathway.
4.3. Erythrocytes from dogs and humans
Erythrocytes from dogs were used to validate the effect of cell adhesion on ATP efflux
observed in human rbcs. Compared to human rbcs, dog rbcs displayed lower basal cAMP
levels, and a modest, non-significant increase of cAMP concentration upon MST7 exposure.
Despite these differences, in both species cell adhesion triggered MST7-induced ATP
release (Figs 4), whereas in non-adhered dog and human rbcs [ATPe] did not change. This
means that in rbcs from humans and dogs adhesion acts as a pre-stimulus potentiating MST7
induction of ATP release.
4.4. Testing the mathematical model
The model designed to explain ATPe kinetics (see Appendix) presents three key features:
1- at any time, [ATPe] is determined by the balance between the rates of ATP release and
ATPe hydrolysis by ectoATPase activity;
2- two different conduits mediate the non-lytic release of ATP;
3- ATP transmembrane transport by these conduits is driven by the chemical gradient of
ATP across the cell membrane, multiplied by a permeability term that accounts for the
kinetics of ATP transport.
In principle, the ATP chemical gradient depends on the difference between [ATPi] and
[ATPe]. In the current experimental conditions, the accumulated [ATPe] is in the nanomolar
range and [ATPi] is in the milimolar range, leaving [ATPi] as the main thermodynamic
parameter driving ATP efflux. Since our results showed that ATPi mass of cells did not vary
during MST7 exposure, [ATPi] should decrease with cell swelling, causing a concomitant
decrease of ATP release. However, in human rbcs, the observed change on [ATPi] had
almost no effect on ATP release (Appendix Fig. 2 C). Conversely, model-dependent fit to
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experimental ATPe kinetics allowed us to calculate the predicted ATP efflux in the absence
of volume change (i.e., MST7 in hyperosmotic medium) or in its presence (i.e., MST7 in
isosmotic medium), showing that changes in cell volume mostly modified the permeability
parameters of ATP transport (see Fig. 2C in Appendix).
4.5. Speculations regarding the role of adhesive forces and the physiological context of
ATPe homeostasis
The quantitative ATPe profile described for human rbcs in the present and in a previous
study [3] is compatible with an in vivo scenario where, under non-stimulated conditions,
[ATPe] is maintained constant at a relatively low value, and acute increases occur in
response to certain physiological and/or pathological conditions.
Provided that in particular areas of the circulation the rates of ATPe hydrolysis by different
ecto and exo nucleotidases of blood cells, the vascular endothelium and plasma are not high
enough, and that paracrine distances from ATP exit are short, rbcs-derived ATPe would then
interact with P2 receptors of the vascular endothelium. As a consequence, the production of
endothelium-derived vasodilators will be stimulated, that will relax the smooth muscle cells
lining the vessels and increase the vascular caliber. In vivo studies using rbcs from humans,
rabbit and mice support the hypothesis that rbcs derived ATPe is an important determinant
of blood flow [6, 49, 52].
It is in this physiological context that cell adhesion might constitute an important signal
modulating ATP release (as observed in this study).
Adhesion of rbcs to other cells is reported to play key roles in various pathological processes
including malarial parasite invasion and sickle cell sequestration, as well as in physiological
processes such as cell senescence [53].
In the future, improved variants of MST7 could be used as pharmacological tools to enhance
ATP release from rbcs. This can be particularly important in the treatment of patients with
diseases such as hyperinsulinemia, type 2 diabetes and primary pulmonary hypertension
among others, where the efflux of ATP in response to various physiological stimuli is highly
diminished. Also, the ability of rbcs to release ATP declines upon a prolonged storage in the
blood banks, and this phenomenon correlates with negative clinical outcomes for patients
receiving transfusions of stored blood [54]. Moreover infective diseases like malaria are
associated with vascular obstruction.
In all these situations, MST7 variants might be used with pharmacological purposes to help
control the production of endothelium-derived vasodilators that mediate the relaxation of the
smooth muscle cells lining the vessels and hence, to control the vascular caliber.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Appendix. Modeling of ATPe kinetics of MST7 challenged rbcs
A simple mathematical model was built to account for the experimentally observed ATPe
kinetics when human erythrocytes were incubated with 10 μM MST7.
In the model, [ATPe] is controlled by the rate of non-lytic ATP release (JR), which accounts
for one or more mechanisms allowing ATP efflux in the absence of lysis, and the rate of
ATPe consumption by ectoATPase activity (JV).
Time dependent changes in [ATPe] are given by
Eq. 1
where JR and JV are the fluxes of ATP release and of ATPe hydrolysis, respectively.
The rate of ATPe consumption (Jv)
A linear expression for the dependence of JV on ATPe concentration was derived
empirically after analyzing data of ectoATPase activity assayed in intact human erythrocytes
suspended in assay medium over an ample range of ATPe concentrations (100–900 nM; see
Fig. 5):
Eq. 2
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Given that MST7 did not affect ectoATPase activity (Fig. 5), kATP was assumed to be
constant throughout the experiment, both in the absence and presence of MST7.
Non-lytic release of ATP (JR)
In human rbcs exposed to MST7, ATP release occurs in the absence of lysis and can thus be
explained by one or more transport mechanisms. Efflux of ATP is assumed to be mediated
by passive, facilitated diffusion as:
Eq. 3
where P denotes a permeability term (whose properties are explained below), and [ATPi]
and [ATPe] are the intracellular and extracellular ATP concentrations, respectively.
As it stands, JR depends on “P” multiplied by the chemical gradient of ATP across the cell
membrane. The electrical ATP gradient, on the other hand, can be calculated as “z. F. Vm”
(where z denotes the electrical charge of ATP, F is the Faraday constant and Vm the
membrane electrical potential). However, even considering that at intracellular pH=7.2 the
electric charge of ATP (a weighted average of all anionic ATP species; see [54]) lies around
−2.4, due to the relative low membrane potential of human rbcs (about −10 mV, [56]) the
electrical ATP gradient represents about 1% of total ATP electrochemical gradient, and was
therefore not considered in Eq. 3.
Since changes in [ATPe] occur in the nanomolar range whereas [ATPi] is millimolar (see
Results) the chemical gradient is approximately equal to [ATPi].
The permeability term of Equation 3
The non-linear accumulation of [ATPe] observed in MST7 stimulated erythrocytes (Fig. 1A)
can be interpreted by assuming time dependent changes in the flux of ATP release (JR). The
model assumes that changes in JR are due to different degrees of activation of the conduits
responsible for ATP efflux. Accordingly, in the unstimulated condition, there is a basal,
isosmotic, stationary state of flux (i). Exposure to MST7 induces an irreversible transition to
a stimulated state (s) followed by a subsequent irreversible decay to a final state (f). For any
given ATP conduit this transition is formulated as the following irreversible process:
where k1 and k2 are first order rate constants that govern the kinetics of this transition. The
fraction of conduit molecules in the initial, stimulated and final states, denoted as xi, xs and
xf, respectively, vary with time according to the following differential mass law equations:
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Eq. 4
Values of x vary from 0 to 1 and at every time are related by:
Eq. 5
The permeability P in Eq. 3 is given by
Eq. 6
so that JR can be now expressed as:
Eq. 7
where pi, ps and pf are the permeability parameters of the initial, stimulated and final conduit
states, respectively. Since the values of these parameters do not change with time, and the
chemical gradient only varies slightly during MST7 induction (see below), the time course
of JR is mainly controlled by the time dependence of xi, xs and xf.
In the case of two conduits undergoing a similar two step transition (i.e., i → s → f, as in
Scheme 1), with each flux being driven by the same chemical gradient (i.e, [ATPi]-[ATPe]),
JR can be expressed as the sum of two fluxes, with each flux exhibiting their corresponding
permeability parameters where both P1 and P2 are described by:
Eq. 8
Eq. 9
Eq. 10
Prior to MST7 exposure,
Eq. 11
so that initial permeabilities for each conduit are given by pi (pi1 and pi2).
Before exposure to MST7, basal ATP release (i.e, JR in the absence of MST7) is assumed to
be balanced by ectoATPase activity (Jv), so that [ATPe] remains steady in the unstimulated
condition.
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To simulate the transition induced by MST7, k1 in Eq. 4 is fixed at zero until the stimulus is
applied.
The final state is given by:
Eq. 12
and thus the permeability parameter for t → ∞ is pf.
Fitting of models to experimental data
Model dependent fits were applied to the experimentally obtained ATPe kinetics, with the
restriction that suitable models should be able to fit simultaneously to profiles of ATPe
accumulation in the absence and presence of carbenoxolone.
We considered a two conduit model accounting for JR1 and JR2 of Eq. 8, where
carbenoxolone completely prevents the activation of JR1 (i.e., k11=0). As shown in
Appendix Fig. 1 A, assuming that both conduits are fully independent yields a poor fit
(dotted lines in inset of Appendix Fig. 1 A). According to the Akaike criterion [57], a much
better fit was attained by assuming a certain degree of interaction between both pathways
(continuous lines in inset of Appendix Fig. 1). Particularly, it was considered that
carbenoxolone not only blocked JR1 activation but also affected the values of parameters k22
and ps2 of Eq 4 and 10.
Effects of cell swelling on ATP chemical gradient
To account for changes in cell volume induced by MST7, [ATPi] can be decomposed as
Eq. 13
with mATPi being the intracellular mass of ATP, and Vt the average cell volume of
erythrocytes at different time points during the experiment. Since MST7 exposure of rbcs
did not vary mATPi, this magnitude was considered constant.
The fluorometric technique used for volumetric experiments quantified time dependent
changes in relative cell volume (Vr; Fig. 2A)
Eq. 14
where volume at time 0 is one (V0) and volume changes at different times (Vt) are related to
this value.
Considering Eqs. 3, 13 and 14, JR can now be expressed as
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Eq. 15
In this equation, values of Vr at any time were obtained by fitting a biexponential function to
the experimentally observed changes in Vr (Fig. 2A).
Predictions of the model to assess the importance of ectoATPase activity
The best fitting model was used to predict the relative importance of ectoATPase activity on
ATPe kinetics. Predictions were made by assuming either kATP = 0 (i.e., blockage of
ectoATPase activity) or kATP= 0.051 min−1 (about 43 times the kATP derived from Fig. 5).
Model fitting
Best fitting values for the parameters, their associated standard errors, and all simulations
shown in Results were numerically obtained with Copasi software, version 4.7 [58]. The
Copasi file describing the model is available upon request.
Appendix Figure 1.
Model fit to experimental ATPe kinetics in the presence of MST7 and predictions of the corresponding ATP fluxes.
A: The model (Equations 1–12 in Appendix) was fitted to the experimental MST7-dependent ATPe kinetics measured in the
absence (red lines) or in the presence of 10 μM carbenoxolone (CBX, green lines). Dotted lines represent fitting of the model
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where two fully independent ATP conduits were assumed, whereas the continuous lines represent a condition where a certain
degree of interaction between the ATP conduits was allowed (as explained in Appendix). Inset: detail of the main graph from 20
to 22 min.
B: After achieving the best fit of the model to experimental data (continuous lines in A), the model predicted the total flux
accounting for ATP release (JR, in nM/min) and the partial fluxes which are either sensitive to CBX (JR1) or resistant to CBX
(JR2). The inset shows a detail of the lower range of JR values.
C: Prediction on the role of ectoATPase activity (Jv) on ATPe kinetics. Red line represents the best fit curve of the model to the
experimental ATPe kinetics (taken from A). The pink line represents the predicted ATPe kinetics assuming full blockage of Jv.
The blue line represents a predicted ATPe kinetics assuming 43-fold higher ectoATPase activity (std Jv) than the experimentally
observed.
Appendix Figure 2.
Model fit to experimental ATPe kinetics from human rbcs in the presence of MST7 under isosmotic and hyperosmotic
conditions. Predictions of the corresponding ATP fluxes.
A: Experimental data (taken from Fig. 2B) show the observed ATPe kinetics for cells exposed to MST7 in isosmotic medium
(MST7) and in hyperosmotic medium (MST7+Hyper). Next, the model of Equations 1–12 (Appendix) was fitted to both
conditions, with best fit values of the parameters given in Appendix Table 1. The lines represent the best fit model.
B: After achieving the best fit of the model to experimental data (lines in A), the corresponding fluxes could be predicted for
MST7 exposed cell in isosmotic medium (red line; JR MST7) and in hyperosmotic medium (green line; JR MST7+Hyper). The
inset shows a detail of data from main graph during the first minutes post stimulus.
C: Effect of cell volume on ATPe kinetics. The red line represents the best fit of the model to ATPe kinetics (similar to A). The
blue line represents a prediction where changes in cell volume are allowed to affect ATP efflux, thereby affecting ATPe
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kinetics. This was done considering the experimental changes in cell volume caused by MST 7 (Fig. 2A), and using Eq. 15 (see
Appendix) to account for cell volume effects on JNL.
Appendix Table 1
Parameters of the model
MST7 MST7+CBX MST7 Hyper
k11 (s−1) 6.2 ± 0.4 0 3.01 ± 0.06
k22 (s−1) 0.32 ± 0.02 1.13 ± 0.02 0.14 ± 0.01
ps1/k21 (107) 58 ± 6 (*) (**)
ps2/k22 (107) 262 ± 5 560 ± 2 187 ± 13
pf total (108 s−1) 111 ± 3 (*) 11 ± 6
pf2 (108 s−1) 50 ± 2 (*) (***)
pi2 (108 s−1) 2.24 ± 0.01 2.76 ± 0.01 2.17 ± 0.05
pe1/k21 . pe2/k22 . 1/pf2 - - 0.013 ± 0.008
k21 (s−1) 1000 (*) (*)
k12 (s−1) 1000 (*) (*)
Results are values of the best fit obtained by fitting the model to experimental data.
(*) Values provided by simultaneous fitting to the data obtained in isosmotic media (Iso) with or without CBX.
(**) This parameter was poorly defined by the fitting to the data obtained in hyperosmotic media (Hyper); it was computed
from the better defined value of pe1/k21. pe2/k22. 1/pf2.
(***) Given that this value was poorly defined by the data it was computed from the value of the ratio pf total/pf2 obtained
under isosmotic conditions.
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Figure 1. ATPe kinetics of MST7-exposed human rbcs
A: Effect of rbcs adhesion on ATPe kinetics. Rbcs were attached to coverslips coated with 0.001% poly-D-lysine (adhered
cells), or loaded on the coverslip surface in the absence of any adherent substrate (non-adhered cells). The arrow indicates
addition of 10 μM MST7.
B: Effect of lysine and poly-D-lysine on ATPe kinetics. Non-adhered rbcs were incubated in media containing either 67 mg/ml
soluble L-lysine (N=2, n=4) or 0.01 mg/ml poly-D-lysine (N=2, n=4). Adhered rbcs were assayed using poly-D-lysine coated
coverslips (as in Fig. 1A) (N=5, n=11). The arrow indicates addition of 10 μM MST7.
C: Effect of pertussis toxin (PTX) and MST17 on ATPe kinetics. Adhered rbcs were exposed to MST7, or pre-incubated 4 h
with PTX (100 ng/mL) before MST7 exposure (N=3, n=5). In separate experiments, cells were exposed to MST17 (N=3, n=4),
an inactive analog of MST7. The arrow indicates addition of 10 μM of either MST7 or MST17.
The time course of [ATPe] (pmol/106 cells and/or nM/40 μl) was quantified by real-time luminometry, as described in Materials
and Methods.
Numbers of determinations (n) from independent preparations (N) are indicated.
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Figure 2. Effect of rbcs volume on ATPe kinetics of MST7 exposed human rbcs
A: Time course of relative cell volume (Vr) of human rbcs exposed to MST7. Rbcs were incubated in 200 μl of isosmotic
medium (298 mosM) and after 20 min cells were exposed to 10 μM MST7 in isosmotic medium (●) or in hyperosmotic medium
(345 mosM; ○). Calibration was performed at the end of each experiment by sequentially exposing rbcs to assay media with the
following osmolarities (in mosM) 298, 280, 255 and 235 or 312, 323 and 340. Results are the mean ± SE of 20–30 rbcs (N=8)
for isosmotic medium and 30–40 rbcs (N=4) for hyperosmotic medium. The red line represents fitting of a biexponential
function to experimental data.
B: Effect of hyperosmotic medium on ATPe kinetics. Rbcs were attached to 0.001% poly-D-lysine-coated coverslips and
stimulated with 10 μM MST7 in isosmotic medium (298 mosM; MST7) or hyperosmotic medium (345 mosM; MST7 Hyper)
(N=3, n=5). The arrow indicates the exposure to stimuli.
Numbers of determinations (n) from independent preparations (N) are indicated.
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Figure 3. Second messengers and intracellular signaling
A: Levels of cAMP from human rbcs exposed to MST7. Rbcs were incubated for 10 min at room temperature under control
conditions (Ctrl), or in the presence of either 10 μM MST7, 100 μM cilostazol (CTZ) + 10 μM MST7, or 100 μM CTZ. Results
are means ± SEM (n=22, N=5) (*, p<0.05, ***, p<0.001, ns: non- significant versus control). The concentration of cAMP was
determined by radio immunoassay using iodinated cyclic AMP-TME (see Materials and Methods).
B: Effects of the PKA inhibitor H-89 on [ATPe]. Adhered rbcs were exposed to 10 μM MST7 in cells pre-exposed for 5 min to
vehicle (MST7) or to 10 μM H-89 (H-89 + MST7) (N=5, n=7). Values of [ATPe] are expressed as ΔATP20, i.e., the difference
between [ATPe] at 20 min post stimulus and basal [ATPe]. Results are means ± SEM. (***, p<0.001). Numbers of
determinations (n) from independent preparations (N) are indicated.
C: Effect of MST7 on cytosolic free calcium concentration ([Ca2+i]). Time-dependent changes in [Ca2+i] were assessed
continuously by fluorescence microscopy using Fluo4-loaded rbcs. The arrow indicates addition of 10 μM MST7. At the end of
each experiment, the signal was calibrated in the presence of ionomycin by adding 0.5 mM EGTA (to obtain minimal
fluorescence intensity) or 2 mM CaCl2 (to obtain maximal fluorescence intensity). Results are means ± SE of 20–30 rbcs (N=4).
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Figure 4. Cell adhesion and cAMP as potential modulators of ATP release in vertebrate rbcs
A: ATPe kinetics of adhered and non-adhered human and dog rbcs. Human and dog rbcs were attached to 0.001% poly-D-
lysine-coated coverslips (adhered cells) or loaded on the coverslip surface in the absence of any adherent substrate (non-adhered
cells). The arrow indicates addition of 10 μM MST7.
B: Correlation plot between [ATPe] and [cAMP] of rbcs from human (●) and dog (○). The concentrations of ATPe and cAMP
were measured before (lower values) and after a 10 min exposure to 10 μM MST7. Results are means ± SE. (*, p<0.05 and ns:
non-significant).
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Figure 5. EctoATPase activity of intact human rbcs
A: The rate of ATPe hydrolysis was determined by following the accumulation of [32P]Pi released from exogenous [γ-32P]ATP
(148–888 nM) added to a rbcs suspension at 20 % hematocrit. At ATP 312 nM the assays were performed in absence or
presence of MST7. Results are expressed as Pi content and are means ± SEM. N=2, n=2 (fmol/106 cells). The continuous lines
represent fitting of an exponential function to experimental data.
B: EctoATPase activity as function of [ATPe]. Close circles represent the initial rate of Pi accumulation ([32P]Pi) obtained from
experimental data of A. The open triangles represent the initial rate of ATPe extinction (ATPe ext.) in non-adhered rbcs
incubated with ATP (100, 200, 320 and 860 nM) and monitored by real-time luminometry. Results are means ± SEM. The
continuous line represents fitting of a linear function to experimental data.
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Figure 6. Conduits of ATP release in human rbcs
A: MST7-dependent ATPe kinetics of rbcs pre-incubated with blockers of ATP release. Prior to MST7 exposure, rbcs were
adhered on 0.001% poly-D-lysine-coated coverslips and pre-incubated for 10 min with 10 or 100 μM carbenoxolone (CBX), 10
μM probenecid (PBC), or 10 μM of both CBX and PBC. The dotted arrow indicates addition of blockers and the full arrow
indicates exposure to 10 μM MST7.
B: MST7-dependent increase of [ATPe] in the absence or presence of the different blockers and calculated from data shown in
A. Values are expressed as ΔATP20, i.e., the difference between [ATPe] at 20 min post stimulus and basal [ATPe]. Results are
means ± SEM. (*, p<0.05, ***, p<0.001 versus MST7 alone).
Denis et al. Page 32
Biochim Biophys Acta. Author manuscript; available in PMC 2014 October 01.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 7. ATP release in mice rbcs
A: Effects of 3V on ATPe kinetics of rbcs from pnx +/+ and pnx −/− mice. Rbcs adhered on 0.001% poly-D-lysine-coated
coverslips were stimulated with 3V (10 μM isoproterenol, 30 μM forskolin and 100 μM) in the absence or presence of 10 μM
CBX. The dotted arrow indicates addition of CBX and full arrow indicates addition of 3V.
B: Effects of MST7 on ATPe kinetics of rbcs from pnx +/+ and pnx −/− mice. Rbcs adhered on 0.001% poly-D-lysine-coated
coverslips were exposed to 10 μM MST7. The arrow indicates exposure to the stimulus.
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Figure 8. Conduits of ATP release in mice rbcs
A: ATPe kinetics of rbcs from pnx+/+ mice pre-incubated with ATP release blockers. Rbcs adhered on 0.001% poly-D-lysine-
coated coverslips were pre-incubated with 10 μM CBX, 10 μM PBC, or 10 μM of both CBX and PBC prior to 10 μM MST7
exposure. The dotted arrow indicates addition of blockers and the full arrow indicates addition of MST7.
B: MST7 dependent increases in [ATPe] in the absence or presence of the different blockers and calculated from data shown in
A. Values are expressed as ΔATP5, i.e., the difference between [ATPe] at 5 min post stimulus and basal [ATPe]. The value of
ΔATP5 of rbcs from pnx−/− mice exposed to MST7 is shown as a white bar. Results are means ± SEM. (*, p<0.05, **, p<0.01,
***, p<0.001 versus pnx+/+ exposed to MST7).
C: ATPe kinetics of rbcs from pnx −/− mice pre-incubated with ATP release blockers. Rbcs adhered on 0.001% poly-D-lysine-
coated coverslips were treated as in A. ATPe kinetics of rbcs from pnx+/+ mice (taken from A) is also shown. The dotted arrow
indicates addition of blockers and the full arrow indicates addition of 10 μM MST7.
D: MST7 dependent increases in [ATPe] in the absence or presence of the different blockers calculated from data of C. Values
are expressed as ΔATP5, i.e., the difference between [ATPe] at 5 min post stimulus and basal [ATPe]. Results are means ±
SEM. (ns: non-significant versus MST7 alone).
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Figure 9. MST7 activation of ATP release in rbcs from pnx+/+, pnx+/− and pnx−/−mice
Cells adhered to 0.001% poly-D-lysine-coated coverslips were exposed to 10 μM MST7. Increases in [ATPe] were evaluated as
the difference between [ATPe] at 5 min post stimulus and basal [ATPe], and are indicated as ΔATP5. Results are means ± SEM.
(* p<0.001 versus pnx+/+ and & p<0.05 versus pnx+/−).
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Figure 10. Effect of 3V on MST7-dependent ATPe release
A: ATPe kinetics of non- adhered human rbcs exposed to 3V, MST7 and MST7+ 3V. Rbcs were loaded on the coverslip surface
in the absence of any adherent substance (non-adhered cells) and exposed to 3V, 10 μM MST7 or 10 μM MST7 + 3V. The
arrow indicates exposure to stimuli.
B: ATPe kinetics of adhered rbcs exposed to 3V and MST7. Rbcs were adhered to 0.001% poly-D-lysine-coated coverslips
(adhered cells) and exposed to 3V or 10 μM MST7. The arrow indicates the exposure to stimulus.
C: Release of [ATPe] induced by different stimuli. Adhered rbcs were exposed to MST7. Non-adhered rbcs were exposed to
MST7 in presence of 3V, 10 μM isoproterenol (Isop) or 30 μM forskolin (FSK). Increases in [ATPe] are expressed as ΔATP20,
i.e., the difference between [ATPe] at 20 min post stimulus and basal [ATPe]. Results are means ± SEM. (***, p<0.001 and ns:
non-significant versus adhered MST7 exposed rbcs).
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Scheme 1.
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